These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 27453470

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Two types of antibodies are induced by vaccination with A/California/2009 pdm virus: binding near the sialic acid-binding pocket and neutralizing both H1N1 and H5N1 viruses.
    Ohshima N, Kubota-Koketsu R, Iba Y, Okuno Y, Kurosawa Y.
    PLoS One; 2014; 9(2):e87305. PubMed ID: 24505283
    [Abstract] [Full Text] [Related]

  • 5. Influenza vaccination strategies targeting the hemagglutinin stem region.
    Fukuyama H, Shinnakasu R, Kurosaki T.
    Immunol Rev; 2020 Jul; 296(1):132-141. PubMed ID: 32542739
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans.
    Nachbagauer R, Wohlbold TJ, Hirsh A, Hai R, Sjursen H, Palese P, Cox RJ, Krammer F.
    J Virol; 2014 Nov; 88(22):13260-8. PubMed ID: 25210189
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.
    Rudenko L, Naykhin A, Donina S, Korenkov D, Petukhova G, Isakova-Sivak I, Losev I, Stukova M, Erofeeva M, Nikiforova A, Power M, Flores J.
    Hum Vaccin Immunother; 2015 Nov; 11(12):2839-48. PubMed ID: 26697973
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K, Yoshida R, Manzoor R, Saito S, Suzuki T, Sasaki M, Saito T, Kida Y, Mori-Kajihara A, Kondoh T, Sato M, Kajihara M, Miyamoto H, Ichii O, Higashi H, Takada A.
    J Virol; 2020 Jun 01; 94(12):. PubMed ID: 32269119
    [Abstract] [Full Text] [Related]

  • 13. Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?
    Neu KE, Henry Dunand CJ, Wilson PC.
    Curr Opin Immunol; 2016 Oct 01; 42():48-55. PubMed ID: 27268395
    [Abstract] [Full Text] [Related]

  • 14. Structural and genetic basis for development of broadly neutralizing influenza antibodies.
    Lingwood D, McTamney PM, Yassine HM, Whittle JR, Guo X, Boyington JC, Wei CJ, Nabel GJ.
    Nature; 2012 Sep 27; 489(7417):566-70. PubMed ID: 22932267
    [Abstract] [Full Text] [Related]

  • 15. Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene.
    Wu NC, Yamayoshi S, Ito M, Uraki R, Kawaoka Y, Wilson IA.
    Cell Host Microbe; 2018 Oct 10; 24(4):569-578.e4. PubMed ID: 30308159
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient.
    Hu W, Chen A, Miao Y, Xia S, Ling Z, Xu K, Wang T, Xu Y, Cui J, Wu H, Hu G, Tian L, Wang L, Shu Y, Ma X, Xu B, Zhang J, Lin X, Bian C, Sun B.
    Virology; 2013 Jan 20; 435(2):320-8. PubMed ID: 23084424
    [Abstract] [Full Text] [Related]

  • 18. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
    Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, Bakker A, Cox F, van Deventer E, Guan Y, Cinatl J, ter Meulen J, Lasters I, Carsetti R, Peiris M, de Kruif J, Goudsmit J.
    PLoS One; 2008 Jan 20; 3(12):e3942. PubMed ID: 19079604
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.
    Sun W, Kirkpatrick E, Ermler M, Nachbagauer R, Broecker F, Krammer F, Palese P.
    J Virol; 2019 Jun 15; 93(12):. PubMed ID: 30944178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.